my take, page-4

MM...at last a rational post.But don't think PR would of helped on way or another. Great PR great to hype up a price or minimize a short term knee jerk reaction, but at the end of the day CCE would stil be where it is. All important will be the next Teleconference - perhaps Sparki can introduce himself ...if he is not collecting his pension cheque that day! Endo fo this month will be lates qtr figures, unfortunately, any revenue performance in Europe prob won't show until the following qtr. Got a feeling Europe (ok maybe wishful thinking) sales have improved dramatically after the slow start.

IN regards to Rocker1 US office cost - TJ will implement cost restraints, so will be intersting to see how thaeyhandle US office.

Regarding the blaming management - I think it's been way overdone - gotta blame someone. Having said that Japan was not handled at all well. Fiona Wood would of stayed on the board had she known of TGA / FDA problems - that shows they really did beleive all would go thru ok. But in hindsight she should of stayed on the board until approval was formalised. And Delta as nonexec Chairman should get off the board for someone
less smarmy. But....in TJ CCE have got a CEO who is the goods and works more in one day than Sparki has in a lifetime (if Sparki has ever held down a job that is - I mean the pension pays pretty well for Spark's standards!) and Fiona continues to be integral to the team.

Of course there will be critcism of the FDA TGA rejections, but certainly as far as FDA is concerned the 501k route was the best way to go. and as far as TGA goes its the TGA who should be answering questions.